FUSION POLYPEPTIDE
Provided is a fusion polypeptide as an antagonist for IL4 and IL13. Also provided is a pharmaceutical composition comprising the fusion polypeptide and a pharmaceutically acceptable excipient.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
14.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is a fusion polypeptide as an antagonist for IL4 and IL13. Also provided is a pharmaceutical composition comprising the fusion polypeptide and a pharmaceutically acceptable excipient. |
---|---|
Bibliography: | Application Number: EP20210822774 |